Filing Flows › Nautilus Biotechnology (NAUT) › Q2 2026
Nautilus Biotechnology (NAUT) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 28, 2026
Nautilus Biotechnology (NAUT) reported revenue of $190K for the second quarter 2026 (Q2 2026).
Nautilus Biotechnology, Q2 2026: revenue $190K, net loss $14.5M, operating cash flow −$13.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $190K | — | — |
| Operating profit | −$14.5M | — | — |
| Net earnings | −$14.5M | — | — |
| Operating cash flow | −$13.7M | — | — |
What changed
Revenue was $190K in Q2 2026.
Operating costs exceeded revenue by $14.5M, an operating margin of -7615.3%. The quarter ended with a net loss of $14.5M.
Operating cash flow was −$13.7M. Non-cash charges added back $300K of depreciation and $1.2M of share-based compensation. Working capital and other items used $715K. Capital expenditures of $454K exceeded it, leaving free cash flow of −$14.2M.
Questions
What was Nautilus Biotechnology's revenue in the second quarter 2026?
Nautilus Biotechnology (NAUT) reported revenue of $190K for the second quarter 2026 (Q2 2026).